Cardiovascular Research

Cardiovascular Research 2001 50(1):162-163; doi:10.1016/S0008-6363(01)00228-0
© 2001 by European Society of Cardiology

This Article Extract FREE Full Text (PDF) E-letters: Submit a response Alert me when this article is cited Alert me when E-letters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Request Permissions Disclaimer Google Scholar Articles by Avkiran, M. Articles by Ytrehus, K. Search for Related Content PubMed PubMed Citation Articles by Avkiran, M. Articles by Ytrehus, K. Social Bookmarking          What's this?

Copyright © 2001, European Society of Cardiology

Na⁺/H⁺ exchange in ischemia, reperfusion and preconditioning

Metin Avkiran^a,*, Garrett Gross^b, Morris Karmazyn^c, Hermann Klein^d, Elizabeth Murphy^e and Kirsti Ytrehus^f

^aCentre for Cardiovascular Biology and Medicine, King's College London, The Rayne Institute, St. Thomas' Hospital, London, SE1 7EH UK
^bMedical College of Wisconsin, Milwaukee, USA
^cUniversity of Western Ontario, London, Canada
^dStädt Krankenanstalten Idar-Oberstein GmbH, Idar-Oberstein, Germany
^eNIEHS/NIH, Research Triangle Park, USA
^fUniversity of Tromso, Tromso, Norway

^* Corresponding author metin.avkiran{at}kcl.ac.uk

Received 16 January 2001; accepted 23 January 2001

We read with interest the recent paper in Cardiovascular Research by Xiao and Allen [1], on the role of the cardiac sarcolemmal Na⁺/H⁺ exchanger (NHE) in ‘reperfusion damage’ and ischemic preconditioning, and the accompanying editorial by Fiolet [2]. The former concludes that (1) NHE is inhibited during ischemia, (2) NHE is activated rapidly during reperfusion and contributes to reperfusion damage and (3) the protective mechanism of preconditioning is NHE inhibition during early reperfusion. However, the validity of these conclusions beyond the specific conditions of the relevant study is debatable.

The first two conclusions are based on the comparable protective efficacy of the specific NHE inhibitor HOE-642 when given from shortly before reperfusion as opposed to from before the onset of ischemia [1], as well as the authors' earlier observation [3,4] that there is only a small rise in [Na⁺]_i during ischemia, which is unaffected by NHE inhibition. Contrary to this, accumulated evidence (see recent reviews [5,6]) indicates that in intact hearts subjected to ischemia and reperfusion in vitro [7–10] and in vivo [11–15], NHE inhibitors are dramatically more effective when given prior to ischemia as opposed to during or shortly before reperfusion, an observation which is consistent with the original report of Karmazyn [16] on the cardioprotective potential of these agents. Furthermore, studies utilising nuclear magnetic resonance spectroscopy (which enables estimation of global [Na⁺]_i) have shown that a substantial rise in [Na⁺]_i occurs during ischemia and that this rise is markedly attenuated by amiloride analogues [17,18] as well as by HOE-642 [19]. Much of this evidence, which suggests that NHE activity is sustained during ischemia and that this activity contributes significantly to the myocardial injury that arises from ischemia and reperfusion, has not been acknowledged by Xiao and Allen [1]. It is noteworthy also that these investigators have themselves noted [3] a significant increase in [Na⁺]_i during ischemia, when they paced their isolated rat heart model at the more physiological rate (for the rat) of 5 Hz (compared with 2 Hz in their recent study [1]); however, they have not reported the effect of NHE inhibition on [Na⁺]_i under this condition.

The third conclusion of the recent paper by Xiao and Allen [1] is based on the observed reduction in NHE activity (as assessed by the [Na⁺]_i and pH_i changes that occurred during exposure to Na⁺ lactate) in preconditioned hearts, and the absence of an additive effect of NHE inhibition with HOE-642 when this was combined with ischemic preconditioning. Whether the [Na⁺]_i and pH_i changes noted during exposure to Na⁺ lactate after 5 min of reperfusion provide an accurate estimation of NHE activity is unclear, because (1) under the conditions employed, the Na⁺/HCO₃^– symporter can also contribute to [Na⁺]_i and pH_i changes, and (2) the NHE is relatively inactive at non-acidic pH_i and exposure to Na⁺ lactate produced little intracellular acidosis (e.g. in Fig. 5, pH_i values after ‘initial acidosis’ are 7.2 in all three examples [1]). Furthermore, as noted by Fiolet [2], any reduction in NHE activity during reperfusion in preconditioned hearts may not necessarily be the underlying mechanism of the observed protection but may instead reflect the improved bioenergetic and ionic preservation of preconditioned myocardium. It is notable also that several earlier studies [8,20,21] have shown that NHE inhibition and ischemic preconditioning do indeed afford additive benefit, which is contrary to the findings of Xiao and Allen [1]. Only one of these studies (by Bugge and Ytrehus [8]) was acknowledged in the recent paper [1], and this was qualified with the statement that "by manipulating the conditions they could observe additive effects of preconditioning and NHE blockade". The phrase "manipulating the conditions" presumably refers to the extension by Bugge and Ytrehus [8] of the ischemic period from 30 min (which produced infarct sizes of 37% in the control group and <7% with NHE inhibition or preconditioning alone, thus leaving no scope for detecting any additive benefit with their combination) to 45 min (which produced infarct sizes of 64% in the control group, 24% with preconditioning, 15% with NHE inhibition, and 4% with the combination of NHE inhibition and preconditioning).

The balance of evidence that is available in this important and clinically relevant field therefore allows alternative conclusions to be drawn, which contradict those of Xiao and Allen [1]. These conclusions are that (1) NHE is active during ischemia and this activity is an important contributor to myocardial injury during ischemia and reperfusion, (2) NHE activity during reperfusion contributes to a much lesser extent to such injury, and (3) preconditioning is unlikely to afford protection by inhibiting NHE activity during reperfusion.

	References

Top References

 

1. Xiao X-H, Allen D.G. Activity of the Na⁺/H⁺ exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart. Cardiovasc Res (2000) 48:244–253.[Abstract/Free Full Text]
2. Fiolet J.W.T. Reperfusion injury and ischemic preconditioning: two sides of a coin? Cardiovasc Res (2000) 48:185–187.[Free Full Text]
3. Park C-O, Xiao X-H, Allen D.G. Changes in intracellular Na⁺ and pH in rat heart during ischemia: role of Na⁺/H⁺ exchanger. Am J Physiol Heart Circ Physiol (1999) 276:H1581–H1590.[Abstract/Free Full Text]
4. Xiao X-H, Allen D.G. Role of Na⁺/H⁺ exchanger during ischemia and preconditioning in the isolated rat heart. Circ Res (1999) 85:723–730.[Abstract/Free Full Text]
5. Avkiran M. Rational basis for use of sodium–hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol (1999) 83:10G–18G.[Web of Science][Medline]
6. Karmazyn M, Gan X.T, Humphreys R.A, et al. The myocardial Na⁺–H⁺ exchange: structure, regulation, and its role in heart disease. Circ Res (1999) 85:777–786.[Abstract/Free Full Text]
7. Hendrikx M, Mubagwa K, Verdonck F, et al. New Na⁺/H⁺ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca²⁺ overload in isolated perfused rabbit heart. Circulation (1994) 89:2787–2798.[Abstract/Free Full Text]
8. Bugge E, Ytrehus K. Inhibition of sodium–hydrogen exchange reduces infarct size in the isolated rat heart: a protection additive to ischaemic preconditioning. Cardiovasc Res (1995) 29:269–274.[Abstract/Free Full Text]
9. Shimada Y, Hearse D.J, Avkiran M. Impact of extracellular buffer composition on cardioprotective efficacy of Na⁺/H⁺ exchanger inhibitors. Am J Physiol (1996) 270:H692–H700.[Medline]
10. Khandoudi N, Laville M-P, Bril A. Protective effect of the sodium/hydrogen exchange inhibitors during global low-flow ischemia. J. Cardiovasc. Pharmacol. (1997) 28:540–546.[CrossRef][Web of Science]
11. Klein H.H, Pich S, Bohle R.M, et al. Myocardial protection by Na⁺–H⁺ exchange inhibition in ischemic, reperfused porcine hearts. Circulation (1995) 92:912–917.[Abstract/Free Full Text]
12. Garcia-Dorado D, Gonzalez M.A, Barrabes J.A, et al. Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na⁺–H⁺ exchange. Cardiovasc Res (1997) 35:80–89.[Abstract/Free Full Text]
13. Miura T, Ogawa T, Suzuki K, et al. Infarct size limitation by a new Na⁺–H⁺ exchange inhibitor, H.O.E. 642: difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol (1997) 29:693–701.[Abstract]
14. Klein H.H, Bohle R.M, Pich S, et al. Time-dependent protection by Na⁺/H⁺ exchange inhibition in a regionally ischemic, reperfused porcine heart preparation with low residual blood flow. J Mol Cell Cardiol (1998) 30:795–801.[CrossRef][Web of Science][Medline]
15. Klein H.H, Pich S, Bohle R.M, et al. Na⁺/H⁺ exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual flow. Circulation (2000) 102:1977–1982.[Abstract/Free Full Text]
16. Karmazyn M. Amiloride enhances postischemic ventricular recovery: possible role of Na⁺–H⁺ exchange. Am J Physiol (1988) 255:H608–H615.[Web of Science][Medline]
17. Murphy E, Perlman M, London R.E, et al. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res (1991) 68:1250–1258.[Abstract/Free Full Text]
18. Pike M.M, Luo C.S, Clark D, et al. NMR measurements of Na⁺ and cellular energy in ischemic rat heart: role of Na⁺/H⁺ exchange. Am J Physiol (1993) 265:H2017–H2026.[Web of Science][Medline]
19. Hartmann M, Decking U.K.M. Blocking Na⁺–H⁺ exchange by cariporide reduces Na⁺-overload in ischemia and is cardioprotective. J Mol Cell Cardiol (1999) 31:1985–1995.[CrossRef][Web of Science][Medline]
20. Shipolini A.R, Yokoyama H, Galiñanes M, et al. Na⁺/H⁺ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation (1997) 96:3617–3625.[Abstract/Free Full Text]
21. Gumina R.J, Buerger E, Eickmeier C, et al. Inhibition of the Na⁺/H⁺ exchanger confers greater cardioprotection against 90 min of myocardial ischemia than ischemic preconditioning in dogs. Circulation (1999) 100:2519–2526.[Abstract/Free Full Text]

CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				C. Shen, M.-J. Lin, A. Yaradanakul, V. Lariccia, J. A. Hill, and D. W. Hilgemann Dual control of cardiac Na+ Ca2+ exchange by PIP2: analysis of the surface membrane fraction by extracellular cysteine PEGylation J. Physiol., August 1, 2007; 582(3): 1011 - 1026. [Abstract] [Full Text] [PDF]

				S. E. Anderson, H. Liu, A. Beyschau, and P. M. Cala Effects of cold cardioplegia on pH, Na, and Ca in newborn rabbit hearts Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1090 - H1097. [Abstract] [Full Text] [PDF]

				S. E. Anderson, D. M. Kirkland, A. Beyschau, and P. M. Cala Acute effects of 17{beta}-estradiol on myocardial pH, Na+, and Ca2+ and ischemia-reperfusion injury Am J Physiol Cell Physiol, January 1, 2005; 288(1): C57 - C64. [Abstract] [Full Text] [PDF]

				A. P Halestrap, S. J Clarke, and S. A Javadov Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection Cardiovasc Res, February 15, 2004; 61(3): 372 - 385. [Abstract] [Full Text] [PDF]

				M. Ten Hove and C. J.A Van Echteld Limited effects of post-ischemic NHE blockade on [Na+]i and pHi in rat hearts explain its lack of cardioprotection Cardiovasc Res, February 15, 2004; 61(3): 522 - 529. [Abstract] [Full Text] [PDF]

				D. G Allen and X.-H. Xiao Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion Cardiovasc Res, March 15, 2003; 57(4): 934 - 941. [Abstract] [Full Text] [PDF]

				S. Anderson Response to: Effect of inhibition of Na+/Ca+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death Cardiovasc Res, September 1, 2002; 55(4): 706 - 707. [Full Text] [PDF]

				D. G Allen and X.-h. Xiao Na+ entry during ischemia, reperfusion and preconditioning Cardiovasc Res, April 1, 2001; 50(1): 164 - 166. [Full Text] [PDF]

This Article Extract FREE Full Text (PDF) E-letters: Submit a response Alert me when this article is cited Alert me when E-letters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Request Permissions Disclaimer Google Scholar Articles by Avkiran, M. Articles by Ytrehus, K. Search for Related Content PubMed PubMed Citation Articles by Avkiran, M. Articles by Ytrehus, K. Social Bookmarking          What's this?

Online ISSN 1755-3245 - Print ISSN 0008-6363

Copyright © 2009 European Society of Cardiology

Oxford Journals Oxford University Press

• Site Map
• Privacy Policy
• Frequently Asked Questions

Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics